Catch up with healthcare and wellness news from the Middle East

Provided by AGP

The Middle East Health Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Middle East Health Journal.

Press releases published on May 13, 2026

Thumbay Group Breaks Ground - Region's First Private, Integrated Psychiatric & Rehab Hospital at Shj Healthcare City
Kent Imaging and Roots Pharmaceutical Announce Distribution Agreement to Bring SnapshotNIR to the GCC and Iraq
Voyager ASGCT Late Breaker: Single IV Dose of VY1706 Well Tolerated, Reduced Tau in 3-Month GLP Toxicology Data; Clinical Trial in Alzheimer’s Disease Expected H2 2026
Zymeworks Announces Participation in Upcoming Investor Conferences
Zenas BioPharma Reports First Quarter 2026 Financial Results and Provides Corporate Update
NVision Expands from Quantum Sensing to Quantum Computing to Accelerate Discovery and Validation of New Therapies
HepaRegeniX to Present Interim Phase 1b Data for Darizmetinib (HRX215) in a Late-Breaking Oral Presentation at the European Association for the Study of the Liver (EASL) Congress 2026
New Anglia University Highlights Growing Demand for International Medical Education Among British Students
Anaveon Appoints Thomas P. Mathers as Chair of the Board of Directors
Inventiva to Present Abstracts at the EASL Congress 2026
Inventiva présentera plusieurs abstracts lors de l’EASL Congress 2026
Fortis Life Sciences vergibt den AbNano® VHH Discovery Grant 2026 an Deliver Biosciences im Bereich der gezielten Wirkstoffabgabe
Fortis Life Sciences attribue la subvention à la découverte AbNano® VHH Discovery 2026 à Deliver Biosciences pour la recherche sur l’administration ciblée de médicaments
Aligos Therapeutics Announces Ten Abstracts Accepted for Presentation at the EASL Congress 2026
Fangzhou Showcases “AI+H2H” Chronic Disease Service Innovations at the National Intelligent Medicine Conference
Assembly Biosciences to Present Topline Phase 1a Data on Hepatitis Delta Virus Entry Inhibitor ABI-6250 at the EASL Congress 2026
Valneva Reports First Quarter 2026 Financial Results and Provides Corporate Updates
Valneva publie ses résultats financiers audités et consolidés pour le premier trimestre 2026
Ascentage Pharma to Present 17 Clinical Advances at 2026 European Hematology Association Congress
VisioCore Under Investigation: The Advanced Eyesight Vision Support Capsules with Organic Ingredients

Share us

on your social networks:

Sign up for:

The Middle East Health Journal

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.